ニュース
The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...
Provisions in the One Big, Beautiful Bill Act capping student loans will make it more difficult for medical students — ...
Neuropathic corneal pain was significantly reduced after 12 weeks of treatment with urcosimod in a phase 2 trial, according ...
Weekend warrior” and regular activity patterns that met current physical activity recommendations reduced the risk for ...
EyePoint Pharmaceuticals completed enrollment in the LUCIA trial, its second phase 3 trial of Duravyu in patients with wet ...
Much of the health-related content about cholesterol on social media, in particular TikTok, is inaccurate, according to ...
Air purifiers may help improve blood pressure control among people living with high concentrations of airborne particulate matter, such as near high-volume roadways, researchers reported.Approximately ...
The link between breast implants and lymphoma is broader than initially believed, results of a cohort study confirmed.Women ...
GLP-1 receptor agonists are associated with risk reductions for dozens of diseases and conditions in addition to rapid weight ...
An oral GLP-1 induced up to 12.4% weight loss at 72 weeks for adults with overweight or obesity, according to topline results ...
The FDA granted accelerated approval to dordaviprone for the treatment of patients aged 1 year and older with recurrent diffuse midline glioma who harbor the H3 K27M mutation with progressive disease ...
In a cohort of midlife adults, mild behavioral impairment may be a reliable marker for impaired executive function, ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する